Mitsubishi Tanabe acquiring NeuroDerm

Mitsubishi Tanabe Pharma Corp. (Tokyo:4508) is acquiring neurology company NeuroDerm Ltd. (NASDAQ:NDRM) for $39 per share, or about $1.1 billion.

Read the full 203 word article

How to gain access

Continue reading with a
two-week free trial.